Global Female Contraceptive Pill Market Research Report 2023

The global Female Contraceptive Pill market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Female Contraceptive Pill is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Female Contraceptive Pill is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Female Contraceptive Pill include Pfizer, Bayer, Teva Pharmaceutical, Allergan,plc, Merck, Mankind Pharma, Piramal Enterprises, Regenex and Syzygy Healthcare, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Female Contraceptive Pill, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Contraceptive Pill.

The Female Contraceptive Pill market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Female Contraceptive Pill market comprehensively. Regional market sizes, concerning products by type, by sales channel and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Female Contraceptive Pill manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by sales channel and by regions.

1.1 Product Overview and Scope of Female Contraceptive Pill

1.2 Female Contraceptive Pill Segment by Type

1.2.1 Global Female Contraceptive Pill Market Value Comparison by Type (2023-2029)

1.2.2 Long-acting Contraceptives

1.2.3 Short-acting Contraceptives

1.2.4 Emergency Contraception

1.3 Female Contraceptive Pill Segment by Sales Channel

1.3.1 Global Female Contraceptive Pill Market Value by Sales Channel: (2023-2029)

1.3.2 Online Store

1.3.3 Hospital

1.3.4 Clinic

1.3.5 Others

1.4 Global Female Contraceptive Pill Market Size Estimates and Forecasts

1.4.1 Global Female Contraceptive Pill Revenue 2018-2029

1.4.2 Global Female Contraceptive Pill Sales 2018-2029

1.4.3 Global Female Contraceptive Pill Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Female Contraceptive Pill Sales Market Share by Manufacturers (2018-2023)

2.2 Global Female Contraceptive Pill Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Female Contraceptive Pill Average Price by Manufacturers (2018-2023)

2.4 Global Female Contraceptive Pill Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Female Contraceptive Pill, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Female Contraceptive Pill, Product Type & Application

2.7 Female Contraceptive Pill Market Competitive Situation and Trends

2.7.1 Female Contraceptive Pill Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Female Contraceptive Pill Players Market Share by Revenue

2.7.3 Global Female Contraceptive Pill Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Female Contraceptive Pill Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Female Contraceptive Pill Global Female Contraceptive Pill Sales by Region: 2018-2029

3.2.1 Global Female Contraceptive Pill Sales by Region: 2018-2023

3.2.2 Global Female Contraceptive Pill Sales by Region: 2024-2029

3.3 Global Female Contraceptive Pill Global Female Contraceptive Pill Revenue by Region: 2018-2029

3.3.1 Global Female Contraceptive Pill Revenue by Region: 2018-2023

3.3.2 Global Female Contraceptive Pill Revenue by Region: 2024-2029

3.4 North America Female Contraceptive Pill Market Facts & Figures by Country

3.4.1 North America Female Contraceptive Pill Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Female Contraceptive Pill Sales by Country (2018-2029)

3.4.3 North America Female Contraceptive Pill Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Female Contraceptive Pill Market Facts & Figures by Country

3.5.1 Europe Female Contraceptive Pill Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Female Contraceptive Pill Sales by Country (2018-2029)

3.5.3 Europe Female Contraceptive Pill Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Female Contraceptive Pill Market Facts & Figures by Country

3.6.1 Asia Pacific Female Contraceptive Pill Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Female Contraceptive Pill Sales by Country (2018-2029)

3.6.3 Asia Pacific Female Contraceptive Pill Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Female Contraceptive Pill Market Facts & Figures by Country

3.7.1 Latin America Female Contraceptive Pill Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Female Contraceptive Pill Sales by Country (2018-2029)

3.7.3 Latin America Female Contraceptive Pill Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Female Contraceptive Pill Market Facts & Figures by Country

3.8.1 Middle East and Africa Female Contraceptive Pill Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Female Contraceptive Pill Sales by Country (2018-2029)

3.8.3 Middle East and Africa Female Contraceptive Pill Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Female Contraceptive Pill Sales by Type (2018-2029)

4.1.1 Global Female Contraceptive Pill Sales by Type (2018-2023)

4.1.2 Global Female Contraceptive Pill Sales by Type (2024-2029)

4.1.3 Global Female Contraceptive Pill Sales Market Share by Type (2018-2029)

4.2 Global Female Contraceptive Pill Revenue by Type (2018-2029)

4.2.1 Global Female Contraceptive Pill Revenue by Type (2018-2023)

4.2.2 Global Female Contraceptive Pill Revenue by Type (2024-2029)

4.2.3 Global Female Contraceptive Pill Revenue Market Share by Type (2018-2029)

4.3 Global Female Contraceptive Pill Price by Type (2018-2029)

5.1 Global Female Contraceptive Pill Sales by Sales Channel (2018-2029)

5.1.1 Global Female Contraceptive Pill Sales by Sales Channel (2018-2023)

5.1.2 Global Female Contraceptive Pill Sales by Sales Channel (2024-2029)

5.1.3 Global Female Contraceptive Pill Sales Market Share by Sales Channel (2018-2029)

5.2 Global Female Contraceptive Pill Revenue by Sales Channel (2018-2029)

5.2.1 Global Female Contraceptive Pill Revenue by Sales Channel (2018-2023)

5.2.2 Global Female Contraceptive Pill Revenue by Sales Channel (2024-2029)

5.2.3 Global Female Contraceptive Pill Revenue Market Share by Sales Channel (2018-2029)

5.3 Global Female Contraceptive Pill Price by Sales Channel (2018-2029)

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Pfizer Female Contraceptive Pill Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Bayer

6.2.1 Bayer Corporation Information

6.2.2 Bayer Description and Business Overview

6.2.3 Bayer Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Bayer Female Contraceptive Pill Product Portfolio

6.2.5 Bayer Recent Developments/Updates

6.3 Teva Pharmaceutical

6.3.1 Teva Pharmaceutical Corporation Information

6.3.2 Teva Pharmaceutical Description and Business Overview

6.3.3 Teva Pharmaceutical Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Teva Pharmaceutical Female Contraceptive Pill Product Portfolio

6.3.5 Teva Pharmaceutical Recent Developments/Updates

6.4 Allergan,plc

6.4.1 Allergan,plc Corporation Information

6.4.2 Allergan,plc Description and Business Overview

6.4.3 Allergan,plc Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Allergan,plc Female Contraceptive Pill Product Portfolio

6.4.5 Allergan,plc Recent Developments/Updates

6.5 Merck

6.5.1 Merck Corporation Information

6.5.2 Merck Description and Business Overview

6.5.3 Merck Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Merck Female Contraceptive Pill Product Portfolio

6.5.5 Merck Recent Developments/Updates

6.6 Mankind Pharma

6.6.1 Mankind Pharma Corporation Information

6.6.2 Mankind Pharma Description and Business Overview

6.6.3 Mankind Pharma Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Mankind Pharma Female Contraceptive Pill Product Portfolio

6.6.5 Mankind Pharma Recent Developments/Updates

6.7 Piramal Enterprises

6.6.1 Piramal Enterprises Corporation Information

6.6.2 Piramal Enterprises Description and Business Overview

6.6.3 Piramal Enterprises Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Piramal Enterprises Female Contraceptive Pill Product Portfolio

6.7.5 Piramal Enterprises Recent Developments/Updates

6.8 Regenex

6.8.1 Regenex Corporation Information

6.8.2 Regenex Description and Business Overview

6.8.3 Regenex Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Regenex Female Contraceptive Pill Product Portfolio

6.8.5 Regenex Recent Developments/Updates

6.9 Syzygy Healthcare

6.9.1 Syzygy Healthcare Corporation Information

6.9.2 Syzygy Healthcare Description and Business Overview

6.9.3 Syzygy Healthcare Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Syzygy Healthcare Female Contraceptive Pill Product Portfolio

6.9.5 Syzygy Healthcare Recent Developments/Updates

6.10 V Care Pharma

6.10.1 V Care Pharma Corporation Information

6.10.2 V Care Pharma Description and Business Overview

6.10.3 V Care Pharma Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.10.4 V Care Pharma Female Contraceptive Pill Product Portfolio

6.10.5 V Care Pharma Recent Developments/Updates

6.11 Lupin

6.11.1 Lupin Corporation Information

6.11.2 Lupin Female Contraceptive Pill Description and Business Overview

6.11.3 Lupin Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Lupin Female Contraceptive Pill Product Portfolio

6.11.5 Lupin Recent Developments/Updates

6.12 HLL Life Care

6.12.1 HLL Life Care Corporation Information

6.12.2 HLL Life Care Female Contraceptive Pill Description and Business Overview

6.12.3 HLL Life Care Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.12.4 HLL Life Care Female Contraceptive Pill Product Portfolio

6.12.5 HLL Life Care Recent Developments/Updates

6.13 Foundation Consumer Healthcare

6.13.1 Foundation Consumer Healthcare Corporation Information

6.13.2 Foundation Consumer Healthcare Female Contraceptive Pill Description and Business Overview

6.13.3 Foundation Consumer Healthcare Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Foundation Consumer Healthcare Female Contraceptive Pill Product Portfolio

6.13.5 Foundation Consumer Healthcare Recent Developments/Updates

6.14 Theramex (Teva)

6.14.1 Theramex (Teva) Corporation Information

6.14.2 Theramex (Teva) Female Contraceptive Pill Description and Business Overview

6.14.3 Theramex (Teva) Female Contraceptive Pill Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Theramex (Teva) Female Contraceptive Pill Product Portfolio

6.14.5 Theramex (Teva) Recent Developments/Updates

7.1 Female Contraceptive Pill Industry Chain Analysis

7.2 Female Contraceptive Pill Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Female Contraceptive Pill Production Mode & Process

7.4 Female Contraceptive Pill Sales and Marketing

7.4.1 Female Contraceptive Pill Sales Channels

7.4.2 Female Contraceptive Pill Distributors

7.5 Female Contraceptive Pill Customers

8.1 Female Contraceptive Pill Industry Trends

8.2 Female Contraceptive Pill Market Drivers

8.3 Female Contraceptive Pill Market Challenges

8.4 Female Contraceptive Pill Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Female Contraceptive Pill Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Female Contraceptive Pill Market Value Comparison by Sales Channel (2023-2029) & (US$ Million)

    Table 3. Global Female Contraceptive Pill Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Female Contraceptive Pill Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Female Contraceptive Pill Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Female Contraceptive Pill Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Female Contraceptive Pill Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Female Contraceptive Pill Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Female Contraceptive Pill, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Female Contraceptive Pill, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Female Contraceptive Pill, Product Type & Application

    Table 12. Global Key Manufacturers of Female Contraceptive Pill, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Female Contraceptive Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Contraceptive Pill as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Female Contraceptive Pill Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Female Contraceptive Pill Sales by Region (2018-2023) & (K Units)

    Table 18. Global Female Contraceptive Pill Sales Market Share by Region (2018-2023)

    Table 19. Global Female Contraceptive Pill Sales by Region (2024-2029) & (K Units)

    Table 20. Global Female Contraceptive Pill Sales Market Share by Region (2024-2029)

    Table 21. Global Female Contraceptive Pill Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Female Contraceptive Pill Revenue Market Share by Region (2018-2023)

    Table 23. Global Female Contraceptive Pill Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Female Contraceptive Pill Revenue Market Share by Region (2024-2029)

    Table 25. North America Female Contraceptive Pill Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Female Contraceptive Pill Sales by Country (2018-2023) & (K Units)

    Table 27. North America Female Contraceptive Pill Sales by Country (2024-2029) & (K Units)

    Table 28. North America Female Contraceptive Pill Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Female Contraceptive Pill Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Female Contraceptive Pill Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Female Contraceptive Pill Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Female Contraceptive Pill Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Female Contraceptive Pill Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Female Contraceptive Pill Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Female Contraceptive Pill Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Female Contraceptive Pill Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Female Contraceptive Pill Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Female Contraceptive Pill Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Female Contraceptive Pill Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Female Contraceptive Pill Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Female Contraceptive Pill Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Female Contraceptive Pill Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Female Contraceptive Pill Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Female Contraceptive Pill Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Female Contraceptive Pill Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Female Contraceptive Pill Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Female Contraceptive Pill Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Female Contraceptive Pill Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Female Contraceptive Pill Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Female Contraceptive Pill Sales (K Units) by Type (2018-2023)

    Table 51. Global Female Contraceptive Pill Sales (K Units) by Type (2024-2029)

    Table 52. Global Female Contraceptive Pill Sales Market Share by Type (2018-2023)

    Table 53. Global Female Contraceptive Pill Sales Market Share by Type (2024-2029)

    Table 54. Global Female Contraceptive Pill Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Female Contraceptive Pill Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Female Contraceptive Pill Revenue Market Share by Type (2018-2023)

    Table 57. Global Female Contraceptive Pill Revenue Market Share by Type (2024-2029)

    Table 58. Global Female Contraceptive Pill Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Female Contraceptive Pill Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Female Contraceptive Pill Sales (K Units) by Sales Channel (2018-2023)

    Table 61. Global Female Contraceptive Pill Sales (K Units) by Sales Channel (2024-2029)

    Table 62. Global Female Contraceptive Pill Sales Market Share by Sales Channel (2018-2023)

    Table 63. Global Female Contraceptive Pill Sales Market Share by Sales Channel (2024-2029)

    Table 64. Global Female Contraceptive Pill Revenue (US$ Million) by Sales Channel (2018-2023)

    Table 65. Global Female Contraceptive Pill Revenue (US$ Million) by Sales Channel (2024-2029)

    Table 66. Global Female Contraceptive Pill Revenue Market Share by Sales Channel (2018-2023)

    Table 67. Global Female Contraceptive Pill Revenue Market Share by Sales Channel (2024-2029)

    Table 68. Global Female Contraceptive Pill Price (US$/Unit) by Sales Channel (2018-2023)

    Table 69. Global Female Contraceptive Pill Price (US$/Unit) by Sales Channel (2024-2029)

    Table 70. Pfizer Corporation Information

    Table 71. Pfizer Description and Business Overview

    Table 72. Pfizer Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Pfizer Female Contraceptive Pill Product

    Table 74. Pfizer Recent Developments/Updates

    Table 75. Bayer Corporation Information

    Table 76. Bayer Description and Business Overview

    Table 77. Bayer Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Bayer Female Contraceptive Pill Product

    Table 79. Bayer Recent Developments/Updates

    Table 80. Teva Pharmaceutical Corporation Information

    Table 81. Teva Pharmaceutical Description and Business Overview

    Table 82. Teva Pharmaceutical Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Teva Pharmaceutical Female Contraceptive Pill Product

    Table 84. Teva Pharmaceutical Recent Developments/Updates

    Table 85. Allergan,plc Corporation Information

    Table 86. Allergan,plc Description and Business Overview

    Table 87. Allergan,plc Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Allergan,plc Female Contraceptive Pill Product

    Table 89. Allergan,plc Recent Developments/Updates

    Table 90. Merck Corporation Information

    Table 91. Merck Description and Business Overview

    Table 92. Merck Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Merck Female Contraceptive Pill Product

    Table 94. Merck Recent Developments/Updates

    Table 95. Mankind Pharma Corporation Information

    Table 96. Mankind Pharma Description and Business Overview

    Table 97. Mankind Pharma Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Mankind Pharma Female Contraceptive Pill Product

    Table 99. Mankind Pharma Recent Developments/Updates

    Table 100. Piramal Enterprises Corporation Information

    Table 101. Piramal Enterprises Description and Business Overview

    Table 102. Piramal Enterprises Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Piramal Enterprises Female Contraceptive Pill Product

    Table 104. Piramal Enterprises Recent Developments/Updates

    Table 105. Regenex Corporation Information

    Table 106. Regenex Description and Business Overview

    Table 107. Regenex Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Regenex Female Contraceptive Pill Product

    Table 109. Regenex Recent Developments/Updates

    Table 110. Syzygy Healthcare Corporation Information

    Table 111. Syzygy Healthcare Description and Business Overview

    Table 112. Syzygy Healthcare Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Syzygy Healthcare Female Contraceptive Pill Product

    Table 114. Syzygy Healthcare Recent Developments/Updates

    Table 115. V Care Pharma Corporation Information

    Table 116. V Care Pharma Description and Business Overview

    Table 117. V Care Pharma Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. V Care Pharma Female Contraceptive Pill Product

    Table 119. V Care Pharma Recent Developments/Updates

    Table 120. Lupin Corporation Information

    Table 121. Lupin Description and Business Overview

    Table 122. Lupin Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. Lupin Female Contraceptive Pill Product

    Table 124. Lupin Recent Developments/Updates

    Table 125. HLL Life Care Corporation Information

    Table 126. HLL Life Care Description and Business Overview

    Table 127. HLL Life Care Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. HLL Life Care Female Contraceptive Pill Product

    Table 129. HLL Life Care Recent Developments/Updates

    Table 130. Foundation Consumer Healthcare Corporation Information

    Table 131. Foundation Consumer Healthcare Description and Business Overview

    Table 132. Foundation Consumer Healthcare Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 133. Foundation Consumer Healthcare Female Contraceptive Pill Product

    Table 134. Foundation Consumer Healthcare Recent Developments/Updates

    Table 135. Theramex (Teva) Corporation Information

    Table 136. Theramex (Teva) Description and Business Overview

    Table 137. Theramex (Teva) Female Contraceptive Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 138. Theramex (Teva) Female Contraceptive Pill Product

    Table 139. Theramex (Teva) Recent Developments/Updates

    Table 140. Key Raw Materials Lists

    Table 141. Raw Materials Key Suppliers Lists

    Table 142. Female Contraceptive Pill Distributors List

    Table 143. Female Contraceptive Pill Customers List

    Table 144. Female Contraceptive Pill Market Trends

    Table 145. Female Contraceptive Pill Market Drivers

    Table 146. Female Contraceptive Pill Market Challenges

    Table 147. Female Contraceptive Pill Market Restraints

    Table 148. Research Programs/Design for This Report

    Table 149. Key Data Information from Secondary Sources

    Table 150. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Female Contraceptive Pill

    Figure 2. Global Female Contraceptive Pill Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Female Contraceptive Pill Market Share by Type in 2022 & 2029

    Figure 4. Long-acting Contraceptives Product Picture

    Figure 5. Short-acting Contraceptives Product Picture

    Figure 6. Emergency Contraception Product Picture

    Figure 7. Global Female Contraceptive Pill Market Value Comparison by Sales Channel (2023-2029) & (US$ Million)

    Figure 8. Global Female Contraceptive Pill Market Share by Sales Channel in 2022 & 2029

    Figure 9. Online Store

    Figure 10. Hospital

    Figure 11. Clinic

    Figure 12. Others

    Figure 13. Global Female Contraceptive Pill Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Female Contraceptive Pill Market Size (2018-2029) & (US$ Million)

    Figure 15. Global Female Contraceptive Pill Sales (2018-2029) & (K Units)

    Figure 16. Global Female Contraceptive Pill Average Price (US$/Unit) & (2018-2029)

    Figure 17. Female Contraceptive Pill Report Years Considered

    Figure 18. Female Contraceptive Pill Sales Share by Manufacturers in 2022

    Figure 19. Global Female Contraceptive Pill Revenue Share by Manufacturers in 2022

    Figure 20. The Global 5 and 10 Largest Female Contraceptive Pill Players: Market Share by Revenue in 2022

    Figure 21. Female Contraceptive Pill Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 22. Global Female Contraceptive Pill Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 23. North America Female Contraceptive Pill Sales Market Share by Country (2018-2029)

    Figure 24. North America Female Contraceptive Pill Revenue Market Share by Country (2018-2029)

    Figure 25. United States Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Canada Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Europe Female Contraceptive Pill Sales Market Share by Country (2018-2029)

    Figure 28. Europe Female Contraceptive Pill Revenue Market Share by Country (2018-2029)

    Figure 29. Germany Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. France Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. U.K. Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Italy Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Russia Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Asia Pacific Female Contraceptive Pill Sales Market Share by Region (2018-2029)

    Figure 35. Asia Pacific Female Contraceptive Pill Revenue Market Share by Region (2018-2029)

    Figure 36. China Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Japan Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. South Korea Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. India Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Australia Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. China Taiwan Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Southeast Asia Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Latin America Female Contraceptive Pill Sales Market Share by Country (2018-2029)

    Figure 44. Latin America Female Contraceptive Pill Revenue Market Share by Country (2018-2029)

    Figure 45. Mexico Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Brazil Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Argentina Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Colombia Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Female Contraceptive Pill Sales Market Share by Country (2018-2029)

    Figure 50. Middle East & Africa Female Contraceptive Pill Revenue Market Share by Country (2018-2029)

    Figure 51. Turkey Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. UAE Female Contraceptive Pill Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Global Sales Market Share of Female Contraceptive Pill by Type (2018-2029)

    Figure 55. Global Revenue Market Share of Female Contraceptive Pill by Type (2018-2029)

    Figure 56. Global Female Contraceptive Pill Price (US$/Unit) by Type (2018-2029)

    Figure 57. Global Sales Market Share of Female Contraceptive Pill by Sales Channel (2018-2029)

    Figure 58. Global Revenue Market Share of Female Contraceptive Pill by Sales Channel (2018-2029)

    Figure 59. Global Female Contraceptive Pill Price (US$/Unit) by Sales Channel (2018-2029)

    Figure 60. Female Contraceptive Pill Value Chain

    Figure 61. Female Contraceptive Pill Production Process

    Figure 62. Channels of Distribution (Direct Vs Distribution)

    Figure 63. Distributors Profiles

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed